Ip2ipo Limited investment portfolio

Apollo Therapeutics Group Limited is a portfolio biopharmaceutical company that translates breakthroughs in biology and basic medical research into innovative medicines, managing over 20 therapeutic programs with six in development. It focuses on developing first‑ or best‑in‑class treatments for serious diseases through a scalable R&D platform and partnerships with leading universities.

C‑Capture Ltd manufactures and develops absorbent materials and solvents for carbon capture and storage, offering reversible CO₂ capture solutions for post‑combustion processes. Its products are aimed at hard‑to‑abate industrial emitters such as cement and glass.